These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26428318)

  • 1. Mitochondrial DNA mutations distinguish bilateral multifocal renal oncocytomas from familial Birt-Hogg-Dubé tumors.
    Lang M; Vocke CD; Merino MJ; Schmidt LS; Linehan WM
    Mod Pathol; 2015 Nov; 28(11):1458-69. PubMed ID: 26428318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of germline BHD mutation on histological concordance and clinical treatment of patients with bilateral renal masses and known unilateral oncocytoma.
    Boris RS; Benhammou J; Merino M; Pinto PA; Linehan WM; Bratslavsky G
    J Urol; 2011 Jun; 185(6):2050-5. PubMed ID: 21496834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases.
    Petersson F; Gatalica Z; Grossmann P; Perez Montiel MD; Alvarado Cabrero I; Bulimbasic S; Swatek A; Straka L; Tichy T; Hora M; Kuroda N; Legendre B; Michal M; Hes O
    Virchows Arch; 2010 Apr; 456(4):355-65. PubMed ID: 20300772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study.
    Benusiglio PR; Giraud S; Deveaux S; Méjean A; Correas JM; Joly D; Timsit MO; Ferlicot S; Verkarre V; Abadie C; Chauveau D; Leroux D; Avril MF; Cordier JF; Richard S;
    Orphanet J Rare Dis; 2014 Oct; 9():163. PubMed ID: 25519458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma.
    Mayr JA; Meierhofer D; Zimmermann F; Feichtinger R; Kögler C; Ratschek M; Schmeller N; Sperl W; Kofler B
    Clin Cancer Res; 2008 Apr; 14(8):2270-5. PubMed ID: 18413815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Birt-Hogg-Dubé syndrome : bilateral oncocytic kidney tumors in a patient].
    Westermann DH; Rüdiger T; Lohe B; Frohneberg D
    Urologe A; 2010 Dec; 49(12):1527-31. PubMed ID: 20949256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.
    Furuya M; Hong SB; Tanaka R; Kuroda N; Nagashima Y; Nagahama K; Suyama T; Yao M; Nakatani Y
    Cancer Sci; 2015 Mar; 106(3):315-23. PubMed ID: 25594584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Birt-Hogg-Dubé syndrome in an overall view: Focus on the clinicopathological prospects in renal tumors.
    Wu J; Lu J; Wu CL; Lu M
    Semin Diagn Pathol; 2024 May; 41(3):119-124. PubMed ID: 38242750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Birt-Hogg-Dubé syndrome: a novel marker of kidney neoplasia.
    Toro JR; Glenn G; Duray P; Darling T; Weirich G; Zbar B; Linehan M; Turner ML
    Arch Dermatol; 1999 Oct; 135(10):1195-202. PubMed ID: 10522666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of mitochondrial DNA D-loop region mutation and its significance in human oncocytoma].
    Song WJ; Yan LM; Zhao XL; Liu ZH; Sun BC
    Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):767-70. PubMed ID: 21163068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma.
    Gasparre G; Hervouet E; de Laplanche E; Demont J; Pennisi LF; Colombel M; Mège-Lechevallier F; Scoazec JY; Bonora E; Smeets R; Smeitink J; Lazar V; Lespinasse J; Giraud S; Godinot C; Romeo G; Simonnet H
    Hum Mol Genet; 2008 Apr; 17(7):986-95. PubMed ID: 18156159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescent and chromogenic in situ hybridization of CEN17q as a potent useful diagnostic marker for Birt-Hogg-Dubé syndrome-associated chromophobe renal cell carcinomas.
    Kato I; Iribe Y; Nagashima Y; Kuroda N; Tanaka R; Nakatani Y; Hasumi H; Yao M; Furuya M
    Hum Pathol; 2016 Jun; 52():74-82. PubMed ID: 26980015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Birt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression.
    Klomp JA; Petillo D; Niemi NM; Dykema KJ; Chen J; Yang XJ; Sääf A; Zickert P; Aly M; Bergerheim U; Nordenskjöld M; Gad S; Giraud S; Denoux Y; Yonneau L; Méjean A; Vasiliu V; Richard S; MacKeigan JP; Teh BT; Furge KA
    BMC Med Genomics; 2010 Dec; 3():59. PubMed ID: 21162720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analyses define differences between BHD-associated renal tumour and sporadic chromophobe renal cell carcinoma.
    Jikuya R; Johnson TA; Maejima K; An J; Ju YS; Lee H; Ha K; Song W; Kim Y; Okawa Y; Sasagawa S; Kanazashi Y; Fujita M; Imoto S; Mitome T; Ohtake S; Noguchi G; Kawaura S; Iribe Y; Aomori K; Tatenuma T; Komeya M; Ito H; Ito Y; Muraoka K; Furuya M; Kato I; Fujii S; Hamanoue H; Tamura T; Baba M; Suda T; Kodama T; Makiyama K; Yao M; Shuch BM; Ricketts CJ; Schmidt LS; Linehan WM; Nakagawa H; Hasumi H
    EBioMedicine; 2023 Jun; 92():104596. PubMed ID: 37182269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Where Birt-Hogg-Dubé meets Cowden syndrome: mirrored genetic defects in two cases of syndromic oncocytic tumours.
    Pradella LM; Lang M; Kurelac I; Mariani E; Guerra F; Zuntini R; Tallini G; MacKay A; Reis-Filho JS; Seri M; Turchetti D; Gasparre G
    Eur J Hum Genet; 2013 Oct; 21(10):1169-72. PubMed ID: 23386036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of BHD in sporadic renal tumors.
    Khoo SK; Kahnoski K; Sugimura J; Petillo D; Chen J; Shockley K; Ludlow J; Knapp R; Giraud S; Richard S; Nordenskjöld M; Teh BT
    Cancer Res; 2003 Aug; 63(15):4583-7. PubMed ID: 12907635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dubé syndrome.
    Schmidt LS; Nickerson ML; Warren MB; Glenn GM; Toro JR; Merino MJ; Turner ML; Choyke PL; Sharma N; Peterson J; Morrison P; Maher ER; Walther MM; Zbar B; Linehan WM
    Am J Hum Genet; 2005 Jun; 76(6):1023-33. PubMed ID: 15852235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetics of renal oncocytosis: a possible model for neoplastic progression.
    Al-Saleem T; Cairns P; Dulaimi EA; Feder M; Testa JR; Uzzo RG
    Cancer Genet Cytogenet; 2004 Jul; 152(1):23-8. PubMed ID: 15193438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterozygous germline FLCN mutation in Birt-Hogg-Dubé syndrome with bilateral renal hybrid oncocytic/chromophobe tumor and unilateral renal chromophobe cell carcinoma: a case report.
    Li J; Liu F; Liu X; Hu Y; Liu Z; Shen Y; Wan J
    J Cancer Res Clin Oncol; 2023 Jun; 149(6):2319-2325. PubMed ID: 36258004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of renal oncocytoma with focus on clinical and pathobiological aspects.
    Kuroda N; Toi M; Hiroi M; Shuin T; Enzan H
    Histol Histopathol; 2003 Jul; 18(3):935-42. PubMed ID: 12792905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.